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INVITED COMMENTARYAngio-Seal Hopes for Antegrade Puncture Require Better Evidence
J.-B. Ricco *, F. Schneider
Department of Vascular Surgery, Hospital Jean Bernard, University of Poitiers, Medical School, FranceIn this issue of the European Journal of Vascular and
Endovascular Surgery, Arindam Chaudhuri et al. raised an
important issue regarding the use of the Angio-Seal device
for both antegrade and retrograde femoral punctures.
Although the authors are correct to point out that deploy-
ment success rates for the Angio-Seal device are very high,
it is less certain that its use for antegrade puncture is safe
for all patients. Vascular access site complications remain of
particular concern in percutaneous interventions (PI). Local
control after PI was achieved by manual compression until
the mid-90s, when a number of vascular closure devices
(VCD) were introduced and commercialized. In principle, the
main advantage of these devices is to shorten the period of
hemostasis and to avoid prolonged immobilization with
earlier patient discharge. The Angio-Seal consists of an
absorbable intravascular anchor, a small bovine plug and an
absorbable traction suture. During deployment the T-sha-
ped anchor is delivered through a customized sheath into
the arterial lumen and is then apposed against the intra-
luminal arterial wall to seal the puncture site. The extra-
vascular collagen plug is subsequently compressed against
the arteriotomy by an absorbable suture. The anchor, plug,
and suture are absorbed between 30 and 90 days.
Using this device with echo-guided puncture and small
sheaths, the authors rightly conclude that the Angio-Seal
device has been effective with a high rate of deployment
success, but the main result of this retrospective study is a
signiﬁcantly higher rate of complications after antegrade
puncture (8.9%) compared with retrograde puncture (3.4%).
The authors also reported one case of femoral artery
stenosis at the puncture site with recurrent claudication at
8 weeks. In this case, open femoral artery exploration
demonstrated a ﬁbrotic nodule arising from within the
arterial wall and occluding the lumen of the artery. Unfor-
tunately, there was no routine duplex scan to detect
femoral stenosis in this group of patients in the months
after the procedure. This lack of follow-up is questionable as
routine use of Angio-Seal is not current practice following
antegrade femoral puncture and it would have been inter-
esting to provide readers with objective data concerning
duplex follow-up of these patients.DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.04.017
* Corresponding author. J.-B. Ricco, Department of Vascular Surgery,
Hospital Jean Bernard, University of Poitiers, Medical School, 86021,
Poitiers Cedex, France.
E-mail address: jeanbaptistericco@gmail.com (J.-B. Ricco).
1078-5884/$ e see front matter  2014 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2014.05.021Moreover, calciﬁcations of the femoral artery and severe
obesity were not described in this series. As these factors
are known to inﬂuence the efﬁciency of VCD, thorough
comparison between manual compression and Angio-Seal
for antegrade and retrograde puncture is not possible
without their appraisal.
Some of the largest prospective randomized trials of
VCDs have been conducted with the Angio-Seal device.
Kussmaul et al.1 showed a signiﬁcant decrease in time to
hemostasis following its use. In this trial, all complications,
including bleeding were less common in the Angio-Seal arm
than in the manual compression arm. Length of hospital
stay has also been reported to be shorter with the Angio-
Seal device.1,2 Complication rates with the Angio-Seal de-
vice range from 0.8% to 3.6%.1,3 The most commonly
occurring complication with the use of the Angio-Seal de-
vice was arterial occlusion of the femoral artery at the
puncture site caused by arterial narrowing and foreign body
reaction caused by the intra-arterial anchor.3
In recent quality improvement guidelines for vascular ac-
cess and closure device use, the Society of Interventional
Radiology (SIR) has emphasized the limitations of currently
available data regarding the latter.4 In that paper, Sheth et al.
showed that the majority of the studies available are single-
institution series that include patients who have few risk
factors for increased vascular complications during vascular
procedures. Examples of such risk factors include age greater
than 70 years, female sex, obesity for antegrade puncture,
body surface area less than 1.6 m2, and calciﬁed femoral
arterial atherosclerosis. None of these factors has been
described in the study by Chaudhuri et al. The SIR concludes
that further study of the safety and efﬁcacy of VCDs in pa-
tients undergoing interventional radiologic procedures is
needed and that femoral angiography should be considered
before deployment of a VCD.They also conclude that there is
insufﬁcient evidence to support the routine use of VCDs for
the express purpose of healthcare cost reduction.
In summary, with the increase of percutaneous arterial
procedures, deﬁnitive control of the access site is an
ongoing problem. Although Angio-Seal devices are associ-
ated with a high rate of technical success, complications
with antegrade puncture continue to occur. As a conse-
quence, close follow-up with duplex monitoring is essential
to ensure awareness of these infrequent but potentially
severe complications.
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